Premier Fund Managers’s Guardant Health GH Stock Holding History

Premier Fund Managers’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-33,700	Closed	-$2.73M	–	215
2020 Q2	$2.73M	Buy	+33,700	New	+$2.72M	0.17%	115

Other funds holding GH

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

Premier Fund Managers's GH Position: Q3 2020 in Review

Premier Fund Managers sold out of Guardant Health (GH) in Q3 2020, closing a stake of 33,700 shares — an estimated $2.73M sold.

Premier Fund Managers first reported a position in GH in Q2 2020 and held it in 1 quarter. The position peaked at $2.73M in Q2 2020. 346 funds tracked by Wall St. Rank hold GH as of Q3 2020.

Premier Fund Managers reported no remaining Guardant Health position as of Q3 2020 after selling out during the quarter.
Premier Fund Managers sold 33,700 Guardant Health shares in Q3 2020, an estimated $2.73M.
Premier Fund Managers first reported a position in Guardant Health in Q2 2020 and held it in 1 quarter.
Premier Fund Managers's Guardant Health position peaked at $2.73M in Q2 2020.
346 funds tracked by Wall St. Rank held Guardant Health as of Q3 2020.

Based on Premier Fund Managers's 13F filing for Q3 2020, filed 13 Nov 2020.